1. Alagol H, Erdem E, Sancak B, Turkmen G, Camlibel M, Bugdayci G. Nitric oxide biosynthesis and malondiadehyde levels in advanced breast cancer. Aust N Z J Surg. 1999. 69:647–650.
Article
2. Ahmad N, Katiyar SK, Mukhtar H. Antioxidants in chemoprevention of skin cancer. Curr Probl Dermatol. 2001. 29:128–139.
Article
3. American Institute of Nutrition. Second report on the AIN Ad Hoc Committee on standards for nutritional studies. J Nutr. 1980. 110:1726.
4. Arab L, Il'yasova D. The epidemiology of tea consumption and colorectal cancer incidence. J Nutr. 2003. 133:3310S–3318S.
Article
5. Barret JR. Plants provide prevention. Environ Health Perspect. 2002. 110:180.
6. Buege JA, Aust SD. Microsomal lipid peroxidation. Methods Enzymol. 1978. 52:302–310.
7. Chen C, Yu R, Owuor ED, Kong AN. Activation of antioxidant-response element (ARE), miotogen-activated protein kinases (MAPKs) and caspases by major green tea polyphenol components during cell survival and death. Arch Pharm Res. 2000. 23:605–612.
Article
8. Conney AH, Lou YR, Xie JG, Osawa T, Newmark HL, Liu Y, Chang RL, Huang MT. Some perspectives on dietary inhibition of carcinogenesis: studies with curcumin and tea. Proc Soc Exp Biol Med. 1997. 216:234–245.
Article
9. Dreosti IE. Bioactive ingredients: antioxidants and polyphenols in tea. Nutr Rev. 1996. 54:S51–S58.
Article
10. Farombi EO, Tahnteng JG, Agboola AO, Nwankwo JO, Emerole GO. Chemoprevention of 2-acetylaminofluorene-induced hepatotoxicity and lipid peroxidation in rats by Kolaviron-A
Garcinia kola Seed Extract. Food Chem Toxicol. 2000. 38:535–541.
Article
11. Feng Q, Kumagai T, Torii Y, Nakamura Y, Osawa T, Uchida K. Anticarcinogenic antioxidants as inhibitors against intracellular oxidative stress. Free Radic Res. 2001. 35:779–788.
Article
12. Gescher AJ, Sharma RA, Steward WP. Cancer chemoprevention by dietary constituents: a tale of failure and promise. Lancet Oncol. 2001. 2:371–379.
Article
13. Guyton KZ, Kensler TW. Prevention of liver cancer. Curr Opin Oncol. 1997. 9:492–496.
Article
14. Habig WH, Pabst MJ, Jakoby WB. Glutathione S-transferase. J Biol Chem. 1974. 249:7130–7139.
15. Henning SM, Niu Y, Liu Y. Bioavailability and antioxidant effect of epigallocatechin gallate administered in purified form versus as green tea extract in healthy individuals. J Nutr Biochem. 2005. 16:610–616.
Article
16. Huang H, Xu X. Anticancer activity of tea: evidence from recent animal experiments and human studies. Journal of Tea Science. 2004. 24:1–11.
17. Ke L, Yu P, Zhang ZX, Huang SS, Huang G, Ma XH. Congou tea drinking and oesophageal cancer in South China. Br J Cancer. 2002. 86:346–347.
Article
18. Korea National Statistical Office. 2007 Annual report on the cause of death statistics. 2008. Seoul. Republic of Korea: Korea National Statistical Office.
19. Lambert JD, Yang CS. Mechanisms of cancer prevention by tea constituents. J Nutr. 2003. 133:3262S–3267S.
Article
20. Lin JK. Cancer chemoprevention by tea polyphenols through modulating signal transduction pathways. Arch Pharm Res. 2002. 25:561–571.
Article
21. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ. Protein measurement with the folin phenol reagent. J Biol Chem. 1951. 193:265–275.
Article
22. McKay DL, Blumberg JB. The role of tea in human health: An update. J Am Coll Nutr. 2002. 21:1–13.
Article
23. Miyata M, Takano H, Guo LQ, Nagata K, Yamazoe Y. Grapefruit juice intake does not enhance but rather protects against aflatoxin B
1-induced liver DNA damage through a reduction in hepatic CYP3A activity. Carcinogenesis. 2004. 25:203–209.
Article
24. Omura T, Sato R. The carbon monoxide-binding pigment of liver microsomes. J Biol Chem. 1964. 239:2370–2378.
Article
25. Ozdemirler G, Aykac G, Uysal M, Oz H. Liver lipid peroxidation and glutathione-related defence enzyme systems in mice treated with paracetamol. J Appl Toxicol. 1999. 14:297–299.
Article
26. Sohn OS, Surace A, Fiala ES, Richie JP, Colosimo S, Zang E, Weisburger JH. Effect of green and black tea on hepatic xenobiotic metabolizing systems in the male F344 rat. Xenobiotica. 1994. 24:119–127.
Article
27. Su LJ, Arab L. Tea consumption and the reduced risk of colon cancer-results from a national prospective cohor study. Public Health Nutr. 2002. 5:419–426.
28. Takada M, Ku Y, Habara K. Inhibitory effect of epigallocatechin-3-gallate on growth and invasion in human biliary tract carcinoma cells. World J Surg. 2002. 26:683–686.
Article
29. Tatematsu M, Mera Y, Inoue T, Satoh K, Sato K, Ito N. Stable phenotypic expression of glutathione S-transferase placental type and unstable phenotypic experssion of γ-glutamyltransferase in rat liver preneoplastic and neoplastic lesion. Carcinogenesis. 1988. 9:215–220.
Article
30. Tian Q, Miller EG, Ahmad H, Tang L, Patil BS. Differential inhibition of human cancer cell proliferation by citrus limonoids. Nutr Cancer. 2001. 40:180–184.
Article
31. Yang CS, Landau JM, Huang MT, Newmark HL. Inhibition of carcinogenesis by dietary polyphenolic compounds. Annu Rev Nutr. 2001. 21:381–406.
Article
32. Yang CS, Maliakal P, Meng X. Inhibition of carcinogenesis by tea. Annu Rev Pharmacol Toxicol. 2002. 42:25–54.
Article
33. Yang G-Y, Liao J, Kim K, Yurkow EH, Yang CS. Inhibition of growth and induction of apoptosis in human cancer cell lines by tea polyphenols. Carcinogenesis. 1998. 19:611–616.
Article